|
||
J. Exp. Med.,
Volume 188, Number 9, November 2, 1998 1621-1632
By


From the * Leukocyte Biology, Division of Biomedical Sciences, Imperial College School of Medicine,
Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, United Kingdom; and Mobilization of bone marrow eosinophils is a critical early step in their trafficking to the lung
during allergic inflammatory reactions. We have shown previously that the cytokine interleukin (IL)-5, generated during an allergic inflammatory reaction in the guinea pig, acts systemically to mobilize eosinophils from the bone marrow. Here, we have investigated the mechanisms underlying this release process. Examination by light and electron microscopy revealed
the rapid migration of eosinophils from the hematopoietic compartment and across the bone
marrow sinus endothelium in response to IL-5. Using an in situ perfusion system of the guinea
pig hind limb, we showed that IL-5 stimulated a dose-dependent selective release of eosinophils from the bone marrow. Eosinophils released from the bone marrow in response to IL-5
expressed increased levels of
Cardiac Medicine, Imperial College School of Medicine at the National Heart and Lung Institute,
Dovehouse Street, London SW3 6LY, United Kingdom
2 integrin and a decrease in L-selectin, but no change in
4 integrin levels. A
2 integrin-blocking antibody markedly inhibited the mobilization of eosinophils
from the bone marrow stimulated by IL-5. In contrast, an
4 integrin blocking antibody increased the rate of eosinophil mobilization induced by IL-5. In vitro we demonstrated that IL-5
stimulates the selective chemokinesis of bone marrow eosinophils, a process markedly inhibited
by two structurally distinct inhibitors of phosphatidylinositol 3-kinase, wortmannin and
LY294002. Wortmannin was also shown to block eosinophil release induced by IL-5 in the
perfused bone marrow system. The parallel observations on the bone marrow eosinophil release process and responses in isolated eosinophils in vitro suggest that eosinophil chemokinesis
is the driving force for release in vivo and that this release process is regulated by
4 and
2 integrins acting in opposite directions.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|